We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-0.08%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$12.6B
AUM Growth
-$158M
Cap. Flow
+$365M
Cap. Flow %
2.9%
Top 10 Hldgs %
35.04%
Holding
2,232
New
759
Increased
357
Reduced
372
Closed
737

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2B
2
PEN icon
Penumbra
PEN
+$150M
3
FPS
Forgent Power Solutions
FPS
+$54.2M
4
CRH icon
CRH
CRH
+$52.3M
5
META icon
Meta Platforms (Facebook)
META
+$52.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$236M
2
AVGO icon
Broadcom
AVGO
+$182M
3
WMT icon
Walmart Inc
WMT
+$158M
4
NVDA icon
NVIDIA
NVDA
+$126M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$103M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.43%
2 Technology 14.31%
3 Healthcare 10.51%
4 Industrials 7.72%
5 Financials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
1526
PUT
Amkor Technology
AMKR
$12.5B
-2,000
Closed -$79K
AMPH icon
1527
Amphastar Pharmaceuticals
AMPH
$919M
-14,929
Closed -$400K
AMPL icon
1528
Amplitude
AMPL
$1.66B
-171,876
Closed -$1.99M
AMPX icon
1529
Amprius Technologies
AMPX
$1.51B
-26,560
Closed -$210K
GOLD
1530
Gold.com Inc
GOLD
$1.34B
-44,531
Closed -$1.52M
ANF icon
1531
Abercrombie & Fitch
ANF
$4.84B
-30,308
Closed -$3.81M
ANGO icon
1532
AngioDynamics
ANGO
$651M
-47,402
Closed -$609K
ANIP icon
1533
ANI Pharmaceuticals
ANIP
$1.73B
-3,078
Closed -$243K
ANIX icon
1534
Anixa Biosciences
ANIX
$126M
-93,931
Closed -$293K
APYX icon
1535
Apyx Medical
APYX
$131M
-87,115
Closed -$305K
ARDX icon
1536
Ardelyx
ARDX
$1B
-55,731
Closed -$325K
ARKK icon
1537
ARK Innovation ETF
ARKK
$6.59B
-2
Closed -$154
ARKK icon
1538
PUT
ARK Innovation ETF
ARKK
$6.59B
-25,000
Closed -$1.92M
AROC icon
1539
Archrock
AROC
$5.58B
-123,129
Closed -$3.2M
ARWR icon
1540
Arrowhead Research
ARWR
$12.3B
-42,011
Closed -$2.79M
ASH icon
1541
PUT
Ashland
ASH
$3.33B
-30,000
Closed -$1.76M
ASLE icon
1542
AerSale
ASLE
$265M
-87,572
Closed -$623K
ASND icon
1543
Ascendis Pharma A/S
ASND
$16.6B
-82,888
Closed -$17.7M
ASPN icon
1544
Aspen Aerogels
ASPN
$430M
-65,470
Closed -$185K
ASTE icon
1545
Astec Industries
ASTE
$1B
-25,701
Closed -$1.11M
ATKR icon
1546
Atkore
ATKR
$3.16B
-124,624
Closed -$7.88M
ATRC icon
1547
AtriCure
ATRC
$2.49B
-8,966
Closed -$355K
ATXS
1548
DELISTED
Astria Therapeutics
ATXS
-48,636
Closed -$637K
AVAV icon
1549
AeroVironment
AVAV
$8.14B
-28,661
Closed -$6.93M
AVGO icon
1550
PUT
Broadcom
AVGO
$1.75T
-1,200
Closed -$415K

Similar funds

Michael Gelband's Q1 2026 Portfolio in Review

As of Q1 2026, Michael Gelband held 2,232 positions worth $12.6B, down 1.2% from $12.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband's Q1 2026 filing shows 759 new, 357 increased, 372 reduced and 737 closed positions. Its largest new stake was Forgent Power Solutions: 1,627,490 shares worth $47.6M. The largest sale was Apple, an estimated $236M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 6.5% a quarter earlier, followed by Technology and Healthcare.

  • Michael Gelband's largest Q1 2026 buy was Forgent Power Solutions: 1,627,490 shares worth $47.6M.
  • Michael Gelband added most to Tesla in Q1 2026, an estimated $2B increase.
  • Michael Gelband's biggest Q1 2026 reduction was Apple, cutting an estimated $236M.
  • Michael Gelband fully exited Walmart Inc in Q1 2026, selling an estimated $158M.
  • Michael Gelband's ten largest holdings make up 35% of its $12.6B portfolio in Q1 2026.
  • Michael Gelband opened 759 new positions and closed 737 in Q1 2026.
  • Michael Gelband's portfolio value fell 1.2% quarter-over-quarter to $12.6B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.